Back
21
Also listed as
LNVGY
OTC
Day Range
$1.20
$1.20
52-Week Range
$0.82
$1.70
Volume
100
50D / 200D Avg
$1.17
/
$1.31
Prev Close
$1.11
Price History
Financial Trends
Peer Comparison
vs Technology sector median (620 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 10.8 | 12.6 |
| P/B | 2.5 | 3.0 |
| ROE % | 23.8 | 8.9 |
| Net Margin % | 2.0 | 5.6 |
| Rev Growth 5Y % | 3.3 | 9.2 |
| D/E | 0.9 | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.17
$0.15 – $0.18
|
95 B | 1 |
| FY2027 |
$0.14
$0.13 – $0.15
|
87 B | 1 |
| FY2026 |
$0.13
$0.12 – $0.14
|
80 B | 1 |
Key Takeaways
Revenue grew 3.27% annually over 5 years — modest growth
Earnings grew 37.01% over the past year
ROE of 23.77% indicates high profitability
Negative free cash flow of -51.33M
P/E of 10.75 — trading at a low valuation
PEG of 0.46 suggests growth is underpriced
Growth
Revenue Growth (5Y)
3.27%
Revenue (1Y)21.48%
Earnings (1Y)37.01%
FCF Growth (3Y)N/A
Quality
Return on Equity
23.77%
ROIC13.76%
Net Margin2.00%
Op. Margin3.13%
Safety
Debt / Equity
0.94
Current Ratio0.93
Interest Coverage2.81
Valuation
P/E Ratio
10.75
P/B Ratio2.45
EV/EBITDA7.32
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.48% | Revenue Growth (3Y) | 5.60% |
| Earnings Growth (1Y) | 37.01% | Earnings Growth (3Y) | -7.20% |
| Revenue Growth (5Y) | 3.27% | Earnings Growth (5Y) | 3.41% |
| Profitability | |||
| Revenue (TTM) | 69.08B | Net Income (TTM) | 1.38B |
| ROE | 23.77% | ROA | 3.13% |
| Gross Margin | 16.07% | Operating Margin | 3.13% |
| Net Margin | 2.00% | Free Cash Flow (TTM) | -51.33M |
| ROIC | 13.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.94 | Current Ratio | 0.93 |
| Interest Coverage | 2.81 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 10.75 | P/B Ratio | 2.45 |
| P/S Ratio | 0.22 | PEG Ratio | 0.46 |
| EV/EBITDA | 7.32 | Dividend Yield | 0.04% |
| Market Cap | 14.89B | Enterprise Value | 15.83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 69.08B | 56.86B | 61.95B | 71.62B | 60.74B |
| Net Income | 1.38B | 1.01B | 1.61B | 2.03B | 1.21B |
| EPS (Diluted) | 0.11 | 0.08 | 0.13 | 0.16 | 0.09 |
| Gross Profit | 11.10B | 9.80B | 10.50B | 12.05B | 9.77B |
| Operating Income | 2.16B | 2.01B | 2.67B | 3.08B | 2.18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 44.22B | 38.75B | 38.92B | 44.51B | 37.99B |
| Total Liabilities | 37.46B | 32.67B | 32.87B | 39.12B | 34.38B |
| Shareholders' Equity | 6.07B | 5.58B | 5.59B | 4.99B | 3.56B |
| Total Debt | 5.73B | 3.96B | 4.36B | 3.83B | 4.46B |
| Cash & Equivalents | 4.78B | 3.56B | 4.25B | 3.93B | 3.07B |
| Current Assets | 27.90B | 22.69B | 22.94B | 29.00B | 23.34B |
| Current Liabilities | 29.98B | 26.06B | 26.09B | 32.76B | 27.37B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#399 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026